Best of 2023: Sarcoma
Radiotherapy increases risk of thoracic STS in breast cancer survivors
Amongst 2 cohorts of US breast cancer survivors, radiotherapy was found to be the strongest risk factor for developing thoracic soft tissue sarcoma (STS), according to a study. In addition, researchers noted that a history of hypertension and diabetes were each associated with an increased risk of angiosarcoma.
Experience Counts: Why Experienced Providers are Needed in Epithelioid Sarcoma Treatment
In this video, Dr. Seth Pollack addresses a crucial question surrounding the treatment of epithelioid sarcoma: the indispensable role of experienced pathologists. Emphasizing the significance of pathology review at major centers with seasoned bone and soft tissue pathologists, Dr. Pollack delves into the risks of misclassification, particularly in the context of epithelioid sarcoma. He highlights the challenges posed by the potential confusion of this cancer with reactive processes, underscoring the need for vigilant evaluation when tumors present, even if initially dismissed by healthcare providers.
Implantable venous access devices outperform PICCs in cancer treatment
Amongst patients with malignant bone and soft tissue tumors of the lower extremities, implantable venous access devices (TIVADs) prolong catheter indwelling time, reduce catheter-related complications, and maintain shoulder joint function better than peripherally inserted central catheters (PICC), according to a study.
Patients with rare cancers want to keep using telemedicine
Patients with sarcoma have benefitted financially from using telemedicine during the pandemic, according to a study that encourages implementing a mixed system of care moving forward. In an online survey, patients with sarcoma were as satisfied with telemedicine appointments as they were with face-to-face appointments, although most (88%) strongly opposed being told bad news virtually. Overall, 57% preferred telemedicine appointments.